CRMD (Cormedix) FFO


CRMD Cormedix Inc CRMD
39 GF Score
Price $7.85
GF Value $66.53
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Cormedix FFO?

FFO (Funds from operations) only applies to REITs.

CRMD
39GF Score
Cormedix Inc CRMD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cormedix (CRMD) Overvalued in 2026?

Based on GuruFocus' analysis, Cormedix stock appears to be undervalued. The current stock price of $7.85 is trading 88.2% below its estimated GF Value™ of $66.53. GuruFocus considers Cormedix to be Possible Value Trap.

Key valuation signals for CRMD:

  • FFO:
  • GF Value™: $66.53 vs. price of $7.85 (88.2% below fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the CRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cormedix Business Description

Other Exchanges 19KA:Germany
Address 389 Interpace Parkway, Suite 450, Parsippany, NJ, USA, 07054
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
39GF Score

Get the complete analysis for CRMD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.85
Price
$66.53
GF Value